Physician profile
Pierre Labrecque
NPI 1902867294
$1,249.19
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $382 · 2021: $300 · 2022: $354 · 2023: $97.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $97.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $97.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $490.78 | 2020-2023 | Tremfya |
| Novartis Pharmaceuticals Corporation | $258.45 | 2019-2023 | |
| Genzyme Corporation | $128.72 | 2021-2023 | |
| Abbvie INC. | $98.27 | 2020-2022 | |
| Lilly USA, LLC | $71.45 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $65.10 | 2020 | |
| Ucb, INC. | $35.79 | 2021 | |
| Amgen INC. | $35.75 | 2022-2023 | Otezla |
| Pfizer INC. | $27.85 | 2021-2023 | |
| Journey Medical Corporation | $23.04 | 2020 | |
| Sun Pharmaceutical Industries INC. | $13.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pierre Labrecque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.